Susquehanna options strategist Alison Edwards notes "steady bullish" options activity in Pfizer (NYSE: PFE) ahead of fourth quarter earnings on Jan. 30th, as investors purchased ~20,000 Feb 38 Calls and 10,000 Feb 38.5 Calls.